Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Talphera | TLPH | 14. jui 2024 | 1.06 | +8.16 |
Tandem Diabetes Care | TNDM | 14. jui 2024 | 45.33 | -0.26 |
Tanger | SKT | 14. jui 2024 | 27.05 | -2.80 |
Tango Therapeutics | TNGX | 14. jui 2024 | 8.93 | +6.44 |
Tantech | TANH | 14. jui 2024 | 0.76 | -3.99 |
Taoping | TAOP | 14. jui 2024 | 0.72 | -5.52 |
Tapestry | TPR | 14. jui 2024 | 41.81 | -1.30 |
Targa Resources | TRGP | 14. jui 2024 | 119.00 | -1.03 |
Target | TGT | 14. jui 2024 | 141.16 | -2.43 |
Target Global Acquisition I A | TGAA | 14. jui 2024 | 11.38 | -0.09 |
Target Global Acquisition I Unit | TGAAU | 14. jui 2024 | 10.81 | 0.00 |
Target Hospitality | TH | 14. jui 2024 | 7.80 | +0.65 |
Taro Pharmaceutical Industries | TARO | 14. jui 2024 | 42.73 | -0.02 |
Tarsus Pharmaceuticals | TARS | 14. jui 2024 | 30.98 | -6.52 |
Taseko Mines | TGB | 14. jui 2024 | 2.32 | +2.65 |
TaskUs A | TASK | 14. jui 2024 | 12.91 | +2.22 |
TAT Technologies | TATT | 14. jui 2024 | 14.99 | -0.73 |
Taylor Devices | TAYD | 14. jui 2024 | 43.34 | -1.50 |
Taylor Morrison Home | TMHC | 14. jui 2024 | 55.49 | -1.46 |
Taysha Gene Therapies | TSHA | 14. jui 2024 | 3.97 | -4.80 |
TC Bancshares | TCBC | 14. jui 2024 | 13.47 | -1.54 |
TC Biopharm ADR | TCBP | 14. jui 2024 | 1.04 | -1.89 |
TC Energy | TRP | 14. jui 2024 | 38.75 | -0.49 |
TCTM Kids IT Education ADR | TCTM | 14. jui 2024 | 1.24 | +6.90 |
TCW Strategic | TSI | 14. jui 2024 | 4.67 | -0.85 |
TD Synnex | SNX | 14. jui 2024 | 129.95 | +0.02 |
TDCX ADR | TDCX | 14. jui 2024 | 7.14 | +0.28 |
TDH Holdings | PETZ | 14. jui 2024 | 1.20 | +2.56 |
TE Connectivity | TEL | 14. jui 2024 | 147.35 | -2.13 |
Team | TISI | 14. jui 2024 | 8.29 | -0.12 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.